Pneumoconiosis primary prevention

Jump to navigation Jump to search

Pneumoconiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumoconiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumoconiosis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumoconiosis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumoconiosis primary prevention

CDC on Pneumoconiosis primary prevention

Pneumoconiosis primary prevention in the news

Blogs on Pneumoconiosis primary prevention

Directions to Hospitals Treating Pneumoconiosis

Risk calculators and risk factors for Pneumoconiosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD

Overview

Effective measures for the primary prevention of pneumoconiosis include preventing exposure to the dust or fiber particle causing the specific pneumoconiosis. [1]

Primary Prevention

Effective measures for the primary prevention of pneumoconiosis include: [2] [3] [4] [5]

References

  1. "StatPearls". 2021. PMID 32310362 Check |pmid= value (help).
  2. Farzaneh MR, Jamshidiha F, Kowsarian S (2010). "Inhalational lung disease". Int J Occup Environ Med. 1 (1): 11–20. PMID 23022777.
  3. Meeker JD, Cooper MR, Lefkowitz D, Susi P (2009). "Engineering control technologies to reduce occupational silica exposures in masonry cutting and tuckpointing". Public Health Rep. 124 Suppl 1: 101–11. doi:10.1177/00333549091244S112. PMC 2708661. PMID 19618812.
  4. Bang KM, Mazurek JM, Wood JM, White GE, Hendricks SA, Weston A; et al. (2015). "Silicosis mortality trends and new exposures to respirable crystalline silica - United States, 2001-2010". MMWR Morb Mortal Wkly Rep. 64 (5): 117–20. PMC 4584686. PMID 25674992.
  5. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE; et al. (2011). "Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers". Am J Respir Crit Care Med. 183 (12): 1680–8. doi:10.1164/rccm.201002-0254OC. PMC 3136994. PMID 21471109.

Template:WH Template:WS